Summary
The function of CD4+CD25+ regulatory T lymphocytes (Treg) in patients with acute coronary syndrome (ACS) and the effects of atorvastatin were investigated. Forty-eight patients with ACS were randomly divided into two groups: group C receiving conventional therapy (n=24), and group C+A receiving conventional therapy+atorvastatin (10 mg/day, n=24). T lymphocytes from ACS patients (before and 2 weeks after the treatment) or 18 healthy subjects were separated and the flow cytometry was used to measure the percentage of Treg. The inhibitory ability of Treg on effector T cells was determined by mixed lymphocyte reaction (MLR). ELISA was used to measure the serum levels of cytokines (IL-10, TGF-β1 and IFN-γ) before and after treatment. The results showed that as compared with normal control group, Treg percentage was decreased significantly (P<0.01), the inhibitory ability of Treg on the T lymphocytes proliferation was reduced (P<0.01), IFN-γ levels were increased and IL-10 and TGF-β1 levels were lowered in ACS patients. After treatment with atorvastatin, Treg percentage and the inhibitory ability of Treg on T lymphocytes proliferation were significantly increased in ACS patients. Serum IFN-γ was decreased significantly, while IL-10 and TGF-β1 were elevated significantly as compared with the non-atorvastatin group. The number of Treg was positively correlated with serum TGF-β1, but negatively with serum IFN-γ and CRP. It was concluded that ACS was associated with decreased number and defected function of Treg, which may play an important role in initiating immune-inflammatory response in ACS. The inhibitory effects of atorvastatin on inflammation in ACS may be due to its beneficial effects on Treg and restoration of immune homeostasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ranjit S, Li D Z, Zeng Q T et al. Differentiation of dendritic cells in monocyte cultures isolated from patients with unstable angina pectoris. Int J Cardiol 2004;97(3):551–556.
Li D Z, Ranjit S, Wu W et al. Dendritic cell mediated heat-shock protein 60 specific T cytotoxicity in acute coronary syndrome. Chin Ciucu J (Chinese), 2005,5:340–343
Sakaguchi S, Sakaguchi N. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol, 2005,24(3–4):211–226
Li D Z, Ranjit S, Zeng Q T et al. Effects of atorvastatin on the function of dendritic cells in patients with unstable angina pectoris. Chin J Intern Med (Chinese), 2004,6:429–432
Fehr T, Kahlert C, Fierz W et al. Statin-induced immunomodulatory effects on human T cells in vivo. Atherosclerosis, 2004,175(1):83–90
Hoshilda S, Nishino M, Tanouchi J et al. Acute Chlamydia pneumoniae infection with heat shock protein 60-related response in patients with acute coronary syndrome. Atherosclerosis, 2005,183(1):109–112
Bacchetta R, Gregori S, Roncarolo M G et al. CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev, 2005,4(8):491–496
Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol, 2005,16(5):518–524
Verginis P, Li H S, Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+ CD25+ T cells. J Immunol, 2005,174(11):7433–7439
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, Z., Li, D., Hu, Y. et al. Changes of CD4+CD25+ regulatory T cells in patients with acute coronary syndrome and the effects of atorvastatin. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 27, 524–527 (2007). https://doi.org/10.1007/s11596-007-0512-4
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-007-0512-4